HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ki-1 (CD30)-positive anaplastic large cell lymphoma, sarcomatoid variant accompanied by spontaneously regressing lymphadenopathy.

Abstract
Although it has been reported that primary Ki-1 (CD30)-positive anaplastic large cell lymphoma (ALCL) of the skin may undergo spontaneous regression, it is rare for ALCL without cutaneous involvement to have spontaneously regressing lymphadenopathy. We report a case of sarcomatoid variant of ALCL accompanied by spontaneously regressing lymphadenopathy. The patient had gastric and pulmonary involvement of ALCL in addition to systemic lymphadenopathy, but with no cutaneous involvement. The lymphadenopathy spontaneously improved gradually during a period of one month without any treatment. At the same time, multiple small nodules in both lung fields decreased on chest computed tomography and multiple elevated gastric tumors with dimples were endoscopically recognized to have improved. He has since been treated with combination chemotherapy because of recurrence of the lymphadenopathy.
AuthorsK Kashiwabara, H Nakamura, H Kusama, K Kishi, H Yagyu, S Takagi, T Matsuoka
JournalInternal medicine (Tokyo, Japan) (Intern Med) Vol. 38 Issue 1 Pg. 49-53 (Jan 1999) ISSN: 0918-2918 [Print] Japan
PMID10052743 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Immunosuppressive Agents
Topics
  • Adult
  • Biopsy
  • Diagnosis, Differential
  • Follow-Up Studies
  • Humans
  • Immunosuppressive Agents (therapeutic use)
  • Lymph Nodes (diagnostic imaging, pathology)
  • Lymphatic Diseases (complications, physiopathology)
  • Lymphoma, Large-Cell, Anaplastic (complications, diagnosis, drug therapy)
  • Male
  • Mediastinum
  • Radionuclide Imaging
  • Recurrence
  • Remission, Spontaneous
  • Tomography, X-Ray Computed

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: